Skip to Main content Skip to Navigation
Journal articles

Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned?

Jean-Paul Bonnefont 1, 2 Fatima Djouadi 3, * Jean-Louis Bresson 4 Jean Bastin 3
* Corresponding author
1 IMAGINE - U1163 - Imagine - Institut des maladies génétiques
2 Service de Génétique Médicale [CHU Necker]
3 T3S - UMR_S 1124 - Toxicité environnementale, cibles thérapeutiques, signalisation cellulaire
4 Unité de recherche clinique / Centre d'investigation clinique [CHU Necker]
Abstract : no abstract
Document type :
Journal articles
Complete list of metadata

Cited literature [2 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-02894834
Contributor : Fatima Djouadi Connect in order to contact the contributor
Submitted on : Thursday, July 9, 2020 - 1:42:07 PM
Last modification on : Wednesday, October 27, 2021 - 4:08:39 PM

File

Vignette du document
version longue 1500mots 10juin...
Files produced by the author(s)

Identifiers

Collections

INSERM | CNRS | UNIV-PARIS5 | UP-SANTE | UP-SCIENCES | UNIV-PARIS

Citation

Jean-Paul Bonnefont, Fatima Djouadi, Jean-Louis Bresson, Jean Bastin. Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned?. Journal of Inherited Metabolic Disease, Springer Verlag, 2015, 38 (2), pp.371-372. ⟨10.1007/s10545-014-9775-7⟩. ⟨inserm-02894834v2⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

87

Files downloads

180